ZA988669B - Resorcinol derivatives. - Google Patents

Resorcinol derivatives.

Info

Publication number: ZA988669B
Authority: ZA; South Africa
Prior art keywords: resorcinol derivatives; resorcinol; derivatives
Prior art date: 1997-09-23

Application number

ZA9808669A

Other languages

English (en)

Inventor

Lan Hu

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-23

Filing date

1998-09-22

Publication date

2000-03-22

1998-09-22 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-03-22 Publication of ZA988669B publication Critical patent/ZA988669B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Inorganic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)

ZA9808669A 1997-09-23 1998-09-22 Resorcinol derivatives. ZA988669B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5962597P	1997-09-23	1997-09-23

Publications (1)

Publication Number	Publication Date
ZA988669B true ZA988669B (en)	2000-03-22

Family

ID=22024176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9808669A ZA988669B (en)	1997-09-23	1998-09-22	Resorcinol derivatives.

Country Status (45)

Country	Link
US (1)	US6132740A (xx)
EP (1)	EP0904774B1 (xx)
JP (2)	JP3591763B2 (xx)
KR (1)	KR100373996B1 (xx)
CN (1)	CN1176647C (xx)
AP (1)	AP857A (xx)
AR (1)	AR012520A1 (xx)
AT (1)	ATE235220T1 (xx)
AU (1)	AU735716C (xx)
BG (1)	BG64524B1 (xx)
BR (1)	BR9803596A (xx)
CA (1)	CA2247748C (xx)
CO (1)	CO5070677A1 (xx)
CZ (1)	CZ297669B6 (xx)
DE (1)	DE69812519T2 (xx)
DK (1)	DK0904774T3 (xx)
DZ (1)	DZ2614A1 (xx)
EA (1)	EA003576B1 (xx)
EG (1)	EG23860A (xx)
ES (1)	ES2192301T3 (xx)
GT (1)	GT199800150A (xx)
HR (1)	HRP20000168B1 (xx)
HU (1)	HUP0003743A3 (xx)
ID (1)	ID24084A (xx)
IL (2)	IL134598A0 (xx)
IS (1)	IS2280B (xx)
MA (1)	MA26548A1 (xx)
MY (1)	MY117805A (xx)
NO (1)	NO327177B1 (xx)
NZ (1)	NZ502797A (xx)
OA (1)	OA11334A (xx)
PA (1)	PA8459901A1 (xx)
PE (1)	PE117299A1 (xx)
PL (1)	PL195192B1 (xx)
PT (1)	PT904774E (xx)
SA (1)	SA98190724B1 (xx)
SI (1)	SI0904774T1 (xx)
SK (1)	SK284983B6 (xx)
TN (1)	TNSN98176A1 (xx)
TR (1)	TR200000782T2 (xx)
TW (1)	TW585780B (xx)
UA (1)	UA57106C2 (xx)
UY (2)	UY25191A1 (xx)
WO (1)	WO1999015148A1 (xx)
ZA (1)	ZA988669B (xx)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HN1996000101A (es)	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
US6414037B1 (en) *	1998-01-09	2002-07-02	Pharmascience	Pharmaceutical formulations of resveratrol and methods of use thereof
FR2777183B1 (fr) *	1998-04-10	2001-03-02	Oreal	Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
FR2777186B1 (fr) *	1998-04-10	2001-03-09	Oreal	Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
HN2000000033A (es) *	1999-03-22	2001-02-02	Pfizer Prod Inc	Composicion de resorcinol
US6878381B2 (en) *	1999-03-22	2005-04-12	Pfizer, Inc	Resorcinol composition
SI1165495T1 (en) *	1999-03-22	2005-08-31	Pfizer	Resorcinol derivatives
US6828460B2 (en) *	1999-03-22	2004-12-07	Pfizer Inc.	Resorcinol derivatives
US20020034772A1 (en) *	1999-06-29	2002-03-21	Orlow Seth J.	Methods and compositions that affect melanogenesis
EP1134207A1 (en) *	2000-03-15	2001-09-19	Pfizer Products Inc.	Process for preparing resorcinol derivatives
IT1318425B1 (it) *	2000-03-24	2003-08-25	D B P Dev Biotechnological Pro	Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
JP4615671B2 (ja) *	2000-04-20	2011-01-19	ポーラ化成工業株式会社	炎症存在下使用用のしわ形成又は皮膚の弾力喪失の防止剤
BR0113798A (pt) *	2000-09-11	2003-07-08	Pfizer Prod Inc	Derivados de resorcinol
BR0114059A (pt) *	2000-09-21	2003-07-01	Pfizer Prod Inc	Derivados de resorcinol
US6514506B1 (en) *	2001-02-14	2003-02-04	Color Access, Inc.	Whitening compositions containing ascomycete derived enzyme
EP1383493A4 (en)	2001-05-02	2005-09-21	Univ New York	INHIBITION OF PIGMENTATION BY INHIBITION OF FATTY ACID SYNTHASE
EP1392673B1 (de) *	2001-05-25	2005-06-08	Wella Aktiengesellschaft	1,3-dihydroxybenzol-derivate und diese verbindungen enthaltende färbemittel
US6863897B2 (en) *	2002-03-22	2005-03-08	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Stabilization of resorcinol derivatives in cosmetic compositions
US6869598B2 (en) *	2002-03-22	2005-03-22	Unilever Home & Personal Care Usa Division Of Conopco, Inc.	Stabilization of sunscreens in cosmetic compositions
WO2003095645A1 (en) *	2002-05-09	2003-11-20	New York University	Assay for melanogenesis
US7977049B2 (en) *	2002-08-09	2011-07-12	President And Fellows Of Harvard College	Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US6852310B2 (en) *	2002-08-23	2005-02-08	Unilever Home & Personal Care Usa Division Of Conopco, Inc.	Skin lightening agents, compositions and methods
US20040109832A1 (en) *	2002-12-09	2004-06-10	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Di-substituted resorcinols as skin lightening agents
US7524485B2 (en) *	2002-12-12	2009-04-28	Unilever Home & Personal Care, Usa, Division Of Conopco, Inc.	Skin lightening agents, compositions and methods
US6875425B2 (en) *	2002-12-12	2005-04-05	Unilever Home & Personal Care Usa	Skin lightening agents, compositions and methods
BRPI0407193A (pt) *	2003-02-03	2006-02-14	Warner Lambert Co	formulação aperfeiçoada para agentes de clareamento da pele
US7338979B2 (en) *	2003-02-11	2008-03-04	Warner-Lambert Company	Depigmentation agents
BRPI0410288A (pt) *	2003-05-20	2006-05-16	Warner Lambert Co	agentes de despigmentação
JP2006528239A (ja) *	2003-05-26	2006-12-14	エンプラニシーオー．，エルティーディ．	レスベラトロルを含有する、美白及び抗酸化作用を有する化粧料組成物、並びに、その製造方法
AU2004253579B2 (en)	2003-07-01	2010-12-23	Biomol International L.P.	Sirt1 modulators for manipulating cells/organism lifespan/stress response
CN100439307C (zh) *	2003-07-08	2008-12-03	荷兰联合利华有限公司	化妆活性物质的制备方法
US20050171027A1 (en)	2003-12-29	2005-08-04	President And Fellows Of Harvard College	Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en)	2003-12-29	2011-09-13	President And Fellows Of Harvard College	Compositions for treating obesity and insulin resistance disorders
US7300646B2 (en) *	2004-02-27	2007-11-27	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Skin lightening agents, compositions and methods
PL1748767T3 (pl)	2004-05-28	2012-08-31	Unigen Inc	1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy
DE602004026647D1 (de) *	2004-09-14	2010-05-27	Ajinomoto Omnichem S A	Topische zusammensetzungen mit phosphorylierten polyphenolen
JP5093998B2 (ja) *	2004-09-22	2012-12-12	大塚製薬株式会社	色素沈着予防又は改善剤
US20060210497A1 (en) *	2005-03-18	2006-09-21	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Novel resorcinol derivatives
US20060210498A1 (en) *	2005-03-18	2006-09-21	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Novel resorcinol derivatives for skin
WO2006138418A2 (en)	2005-06-14	2006-12-28	President And Fellows Of Harvard College	Improvement of cognitive performance with sirtuin activators
JP5244400B2 (ja) *	2005-12-26	2013-07-24	株式会社林原	アルキルレゾルシノール配糖体とその製造方法並びに用途
WO2007077259A1 (en) *	2006-01-05	2007-07-12	Symrise Gmbh & Co. Kg	Synergistic active preparations comprising diphenylmethane derivatives and further skin and/or hair lightening and/or senile keratosis reducing compounds
US7247294B1 (en)	2006-03-30	2007-07-24	Conopco, Inc.	Skin lightening agents, compositions and methods
US7270805B1 (en)	2006-03-30	2007-09-18	Conopco, Inc.	Skin lightening agents, compositions and methods
US7250158B1 (en)	2006-03-30	2007-07-31	Conopco, Inc.	Skin lightening agents, compositions and methods
RU2428167C2 (ru) *	2006-06-19	2011-09-10	Курарей Ко., Лтд.	Препарат для наружного нанесения на кожу, обладающий повышенной стабильностью
JP5132095B2 (ja) *	2006-07-13	2013-01-30	ポーラ化成工業株式会社	エマルション剤形の皮膚外用剤
JP4990574B2 (ja) *	2006-07-13	2012-08-01	ポーラ化成工業株式会社	新規化合物及びそれを含有する皮膚外用剤
DE102007038097A1 (de)	2007-08-13	2009-02-19	Merck Patent Gmbh	Tyrosinaseinhibitoren
DE102007038098A1 (de)	2007-08-13	2009-02-19	Merck Patent Gmbh	Tyrosinaseinhibitoren
WO2009064492A1 (en) *	2007-11-14	2009-05-22	New York University School Of Medicine	Quinoline compounds as melanogenesis modifiers and uses thereof
WO2009064493A1 (en) *	2007-11-14	2009-05-22	New York University School Of Medicine	Tricyclic compounds as melanogenesis modifiers and uses thereof
US20100040568A1 (en) *	2008-04-30	2010-02-18	Skinmedica, Inc.	Steroidal compounds as melanogenesis modifiers and uses thereof
US20100010100A1 (en) *	2008-07-09	2010-01-14	Hinman Andrew W	Dermatological compositions with anti-aging and skin even-toning properties
ES2998662T3 (en) *	2008-07-21	2025-02-21	Unigen Inc	Skin-whitening (lightening) compounds
US20100029784A1 (en) *	2008-07-30	2010-02-04	Hinman Andrew W	Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
FR2939135B1 (fr) *	2008-12-02	2010-12-03	Galderma Res & Dev	Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939136B1 (fr) *	2008-12-02	2010-12-03	Galderma Res & Dev	Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2953834B1 (fr)	2009-12-10	2012-01-13	Galderma Res & Dev	Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
JP4825921B1 (ja) *	2010-07-16	2011-11-30	株式会社資生堂	４−アルキルレゾルシノール誘導体及びこれを含有する皮膚外用剤
WO2012103487A1 (en)	2011-01-27	2012-08-02	New York University	Coumarin compounds as melanogenesis modifiers and uses thereof
KR102257469B1 (ko)	2011-03-24	2021-05-27	유니젠, 인크.	디아릴프로판의 제조를 위한 화합물 및 방법
EP2964182B1 (en)	2013-03-08	2018-02-14	Unilever PLC, a company registered in England and Wales under company no. 41424 of	Resorcinol compounds for dermatological use
RU2582215C1 (ru) *	2015-01-16	2016-04-20	Александр Ливиевич Ураков	Способ обесцвечивания кожи в области кровоподтека
WO2017079905A1 (en) *	2015-11-10	2017-05-18	Henkel Ag & Co. Kgaa	A cosmetic composition for skin brightening
WO2017215863A1 (en)	2016-06-15	2017-12-21	Unilever N.V.	Method and cosmetic composition for enhanced transdermal delivery of alkyl substituted resorcinol
KR102667506B1 (ko) *	2016-06-30	2024-05-20	시므라이즈 아게	레조르시놀 유도체를 포함하는 약제 및 화장품 조성물
EA201992520A1 (ru) *	2017-07-12	2020-06-25	Юнилевер Н.В.	Масло, улучшающее композицию для кожи
IT201700104536A1 (it)	2017-09-19	2019-03-19	Cmed Aesthetics Srl	Prodotti topici con sistema bifasico
EP3996664B1 (en)	2019-07-12	2024-08-21	Unilever Global IP Limited	Stabilization of resorcinol compounds in cosmetic compositions
EP4051225A4 (en) *	2019-10-30	2023-07-19	Dow Global Technologies LLC	SUN CARE COMPOSITIONS COMPRISING HOLLOW MESOPOROUS SILICA NANOSPHERES
US20230165772A1 (en)	2020-04-28	2023-06-01	Conopco, Inc., D/B/A Unilever	Stabilized cosmetic compositions with n, n'-di-acetyl cystine
CN114315527B (zh) *	2021-12-29	2024-06-11	苏州博研医药科技有限公司	一种间苯二酚的制备方法
CN120826212A (zh)	2022-12-21	2025-10-21	联合利华知识产权控股有限公司	具有吲哚的配方的颜色稳定化
WO2025140839A1 (en)	2023-12-29	2025-07-03	Unilever Ip Holdings B.V.	Colour stabilization of formulae with boron nitride
WO2025225705A1 (ja) *	2024-04-25	2025-10-30	国立大学法人富山大学	メラニン分解促進剤及びメラニン産生抑制剤

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1131200A (en) *	1966-06-06	1968-10-23	Fuji Photo Film Co Ltd	Process for the production of polymer images by the polymerization of vinyl compounds
BE713299A (xx) *	1967-04-06	1968-08-16
US3933925A (en) *	1972-06-29	1976-01-20	Koppers Company, Inc.	Hydrolysis of toluene diamines to produce methyl resorcinols
US4006218A (en) *	1974-07-08	1977-02-01	Johnson & Johnson	Potentiated medicaments
DE2616479C2 (de) *	1976-04-14	1986-12-04	Brickl, Rolf, Dr., 7951 Warthausen	Substituierte Fluoracylresorcine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel und Kosmetika
DE3127590A1 (de) *	1980-07-12	1982-08-12	Kozak, Pavel, 6600 Saarbrücken	Mittel fuer die externe behandlung von hautkrakheiten
US4391827A (en) *	1980-09-08	1983-07-05	Pfizer Inc.	3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor
US4526179A (en) *	1983-01-28	1985-07-02	Leonard Salesky	Digital apical foramen locating apparatus
DE3604865A1 (de) *	1986-02-15	1987-08-20	Walter Dr Med Langbehn	Haut-kosmetikum
JPH0651619B2 (ja) *	1988-05-09	1994-07-06	株式会社クラレ	美白剤
US4985157A (en) *	1989-05-01	1991-01-15	Mobil Oil Corporation	Mixed alkoxylated alcohol-hydroquinone/resorcinol borates-antioxidants
US5059438A (en) *	1990-02-05	1991-10-22	Enzytech, Inc.	Compositions and methods for inhibiting browning in foods using resorcinol derivatives
JPH054905A (ja) *	1990-10-31	1993-01-14	Pola Chem Ind Inc	化粧料
JP2801960B2 (ja) *	1990-10-31	1998-09-21	ポーラ化成工業株式会社	頭髪化粧料
JP2875374B2 (ja) *	1990-10-31	1999-03-31	ポーラ化成工業株式会社	ニキビ用化粧料
FR2679133B1 (fr) *	1991-07-17	1993-10-15	Oreal	Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
EP0524439A1 (en) *	1991-07-24	1993-01-27	F.Hoffmann-La Roche & Co. Aktiengesellschaft	Novel cyclohexane and tetrahydropyran derivatives and antifungal compositions containing these derivatives
SK280617B6 (sk) *	1992-01-16	2000-05-16	Hoechst Aktiengesellschaft	Arylcykloalkylové deriváty, spôsob ich prípravy, f
CA2094465A1 (en) *	1992-04-23	1993-10-24	Pierre Andre Raymond Bruneau	Cycloalkane derivatives
US5399785A (en) *	1992-08-05	1995-03-21	Nippon Paint Co., Ltd.	Tyrosinase activity inhibitor
JPH0656641A (ja) *	1992-08-05	1994-03-01	Nippon Paint Co Ltd	化粧料
FR2704428B1 (fr) *	1993-04-29	1995-06-09	Oreal	Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante.
FR2704753B1 (fr) *	1993-05-06	1995-06-30	Oreal	Utilisation de derives de la 4-thio resorcine ou 4-thio 1-3-dihydroxybenzene, dans des compositions cosmetiques ou dermopharmaceutiques a action depigmentante.
GB9418762D0 (en) *	1994-09-16	1994-11-02	Bayer Ag	Use of substituted cyclopentane-DI-and-triones
JP2790986B2 (ja) *	1995-02-27	1998-08-27	住友建設株式会社	橋脚の構築方法及び施工方法

1998
- 1998-08-23 BR BR9803596-7A patent/BR9803596A/pt not_active Application Discontinuation
- 1998-09-15 US US09/153,479 patent/US6132740A/en not_active Expired - Fee Related
- 1998-09-16 SI SI9830403T patent/SI0904774T1/xx unknown
- 1998-09-16 PT PT98307523T patent/PT904774E/pt unknown
- 1998-09-16 DE DE69812519T patent/DE69812519T2/de not_active Expired - Lifetime
- 1998-09-16 ES ES98307523T patent/ES2192301T3/es not_active Expired - Lifetime
- 1998-09-16 DK DK98307523T patent/DK0904774T3/da active
- 1998-09-16 AT AT98307523T patent/ATE235220T1/de not_active IP Right Cessation
- 1998-09-16 EP EP98307523A patent/EP0904774B1/en not_active Expired - Lifetime
- 1998-09-17 AP APAP/P/1998/001349A patent/AP857A/en active
- 1998-09-17 JP JP26259798A patent/JP3591763B2/ja not_active Expired - Fee Related
- 1998-09-20 EG EG115598A patent/EG23860A/xx active
- 1998-09-21 PL PL98339551A patent/PL195192B1/pl not_active IP Right Cessation
- 1998-09-21 TR TR2000/00782T patent/TR200000782T2/xx unknown
- 1998-09-21 AU AU89946/98A patent/AU735716C/en not_active Ceased
- 1998-09-21 ID IDW20000553A patent/ID24084A/id unknown
- 1998-09-21 EA EA200000251A patent/EA003576B1/ru not_active IP Right Cessation
- 1998-09-21 AR ARP980104713A patent/AR012520A1/es active IP Right Grant
- 1998-09-21 NZ NZ502797A patent/NZ502797A/en unknown
- 1998-09-21 WO PCT/IB1998/001451 patent/WO1999015148A1/en not_active Ceased
- 1998-09-21 CN CNB988091267A patent/CN1176647C/zh not_active Expired - Fee Related
- 1998-09-21 MY MYPI98004323A patent/MY117805A/en unknown
- 1998-09-21 IL IL13459898A patent/IL134598A0/xx not_active IP Right Cessation
- 1998-09-21 HR HR20000168A patent/HRP20000168B1/xx not_active IP Right Cessation
- 1998-09-21 CZ CZ20001037A patent/CZ297669B6/cs not_active IP Right Cessation
- 1998-09-21 HU HU0003743A patent/HUP0003743A3/hu unknown
- 1998-09-21 SK SK378-2000A patent/SK284983B6/sk not_active IP Right Cessation
- 1998-09-21 KR KR10-2000-7003026A patent/KR100373996B1/ko not_active Expired - Fee Related
- 1998-09-21 UA UA2000031611A patent/UA57106C2/uk unknown
- 1998-09-21 CA CA002247748A patent/CA2247748C/en not_active Expired - Fee Related
- 1998-09-22 PE PE1998000904A patent/PE117299A1/es not_active Application Discontinuation
- 1998-09-22 MA MA25269A patent/MA26548A1/fr unknown
- 1998-09-22 TN TNTNSN98176A patent/TNSN98176A1/fr unknown
- 1998-09-22 GT GT199800150A patent/GT199800150A/es unknown
- 1998-09-22 ZA ZA9808669A patent/ZA988669B/xx unknown
- 1998-09-22 DZ DZ980224A patent/DZ2614A1/xx active
- 1998-09-22 PA PA19988459901A patent/PA8459901A1/es unknown
- 1998-09-22 TW TW087115791A patent/TW585780B/zh not_active IP Right Cessation
- 1998-09-23 UY UY25191A patent/UY25191A1/es not_active Application Discontinuation
- 1998-09-23 CO CO98055164A patent/CO5070677A1/es unknown
- 1998-11-08 SA SA98190724A patent/SA98190724B1/ar unknown
1999
- 1999-06-08 UY UY25550A patent/UY25550A1/es not_active Application Discontinuation
2000
- 2000-02-15 IS IS5376A patent/IS2280B/is unknown
- 2000-03-10 OA OA1200000070A patent/OA11334A/en unknown
- 2000-03-16 BG BG104247A patent/BG64524B1/bg unknown
- 2000-03-22 NO NO20001473A patent/NO327177B1/no not_active IP Right Cessation
2004
- 2004-04-20 JP JP2004123687A patent/JP2004210799A/ja active Pending
2005
- 2005-08-29 IL IL170545A patent/IL170545A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
SK3782000A3 (en)	2001-06-11
AU8994698A (en)	1999-04-12
BG64524B1 (bg)	2005-06-30
NO327177B1 (no)	2009-05-04
DE69812519D1 (de)	2003-04-30
TNSN98176A1 (fr)	2005-03-15
MY117805A (en)	2004-08-30
PE117299A1 (es)	1999-11-18
TR200000782T2 (tr)	2000-09-21
HUP0003743A2 (hu)	2001-04-28
MA26548A1 (fr)	2004-12-20
CA2247748A1 (en)	1999-03-23
HRP20000168A2 (en)	2000-08-31
NZ502797A (en)	2002-04-26
EP0904774B1 (en)	2003-03-26
EP0904774A1 (en)	1999-03-31
OA11334A (en)	2003-12-10
ID24084A (id)	2000-07-06
IS5376A (is)	2000-02-15
IS2280B (is)	2007-09-15
UA57106C2 (uk)	2003-06-16
AP857A (en)	2000-07-11
PL339551A1 (en)	2000-12-18
CO5070677A1 (es)	2001-08-28
BR9803596A (pt)	2000-04-25
AP9801349A0 (en)	1998-09-30
HK1028344A1 (en)	2001-02-16
IL134598A0 (en)	2001-04-30
AR012520A1 (es)	2000-10-18
EA200000251A1 (ru)	2000-08-28
TW585780B (en)	2004-05-01
CZ20001037A3 (cs)	2001-02-14
PT904774E (pt)	2003-08-29
KR100373996B1 (ko)	2003-02-26
AU735716C (en)	2007-03-29
PL195192B1 (pl)	2007-08-31
SK284983B6 (sk)	2006-03-02
JPH11152203A (ja)	1999-06-08
JP2004210799A (ja)	2004-07-29
EA003576B1 (ru)	2003-06-26
HUP0003743A3 (en)	2006-02-28
US6132740A (en)	2000-10-17
CN1176647C (zh)	2004-11-24
DE69812519T2 (de)	2003-12-11
PA8459901A1 (es)	2000-05-24
UY25550A1 (es)	2000-02-23
UY25191A1 (es)	2001-08-27
DK0904774T3 (da)	2003-06-16
CN1270509A (zh)	2000-10-18
JP3591763B2 (ja)	2004-11-24
SA98190724B1 (ar)	2006-05-20
NO20001473L (no)	2000-03-22
ES2192301T3 (es)	2003-10-01
SI0904774T1 (en)	2003-10-31
ATE235220T1 (de)	2003-04-15
HRP20000168B1 (en)	2006-07-31
WO1999015148A1 (en)	1999-04-01
DZ2614A1 (fr)	2003-03-01
IL170545A (en)	2010-04-29
GT199800150A (es)	2000-03-15
BG104247A (en)	2000-11-30
AU735716B2 (en)	2001-07-12
KR20010024217A (ko)	2001-03-26
CZ297669B6 (cs)	2007-02-28
EG23860A (en)	2007-11-18
CA2247748C (en)	2002-07-02
NO20001473D0 (no)	2000-03-22

Publication	Publication Date	Title
ZA988669B (en)	2000-03-22	Resorcinol derivatives.
ZA99254B (en)	1999-07-16	Benzosulfone derivatives.
ZA996185B (en)	2000-04-10	Sulfanylsilanes.
ZA200005136B (en)	2001-03-02	Dihydropyrimides.
ZA986905B (en)	2000-01-31	Substituted quinazoline derivatives.
ZA9811339B (en)	1999-07-08	Benzamidine derivatives.
ZA987489B (en)	2000-02-21	Fungicidal 2-methoxybenzophenones.
ZA97521B (en)	1997-08-04	19-Nor-pregnene derivatives.
ZA984158B (en)	1999-11-19	Tetrazoles.
ZA981017B (en)	1999-08-10	2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines.
IL126624A0 (en)	1999-08-17	3-descladinose-2, 3-anhydroerythromycin derivatives
DE59804842D1 (en)	2002-08-22	Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA981926B (en)	1999-09-06	Detergent--package combination.
ZA987058B (en)	2000-02-07	Substituted 4-benzoylpyrazoles.
ZA987055B (en)	2000-02-07	Substituted 4-benzoylpyrazoles.
ZA992443B (en)	1999-10-01	Hydroxy-methyl-hexanones.
ZA991550B (en)	1999-08-26	Cyclohexanediole derivatives.
ZA974953B (en)	1997-12-08	Substituted pyrazolylpyrazole derivatives.
ZA993123B (en)	1999-11-08	Trisresorcinyltriazines.
ZA982436B (en)	1999-09-23	Thiazolimine derivatives.
ZA995325B (en)	2000-02-22	Methylcyclotetradec-5-en-1-ones.
ZA983705B (en)	1999-11-01	Pregnan-3-ol-20-ones.
MXPA98005558A (es)	2004-01-29	Sistema de estabilizacion estructural.
ZA987B (en)	1999-07-02	Substituted 4-benzoylpyrazoles.
ZA988206B (en)	2000-03-09	Piperidinylmethyloxazolidinone derivative.